217 related articles for article (PubMed ID: 2306456)
21. Interaction of lipophilic peptides derived from mastoparan with phospholipid vesicles.
Niidome T; Kawakami R; Okamoto K; Ohmori N; Mihara H; Aoyagi H
J Pept Res; 1997 Dec; 50(6):458-64. PubMed ID: 9440047
[TBL] [Abstract][Full Text] [Related]
22. A conserved motif in the tail domain of vinculin mediates association with and insertion into acidic phospholipid bilayers.
Johnson RP; Niggli V; Durrer P; Craig SW
Biochemistry; 1998 Jul; 37(28):10211-22. PubMed ID: 9665728
[TBL] [Abstract][Full Text] [Related]
23. A peptide of nine amino acid residues from alpha-sarcin cytotoxin is a membrane-perturbing structure.
Mancheño JM; Martínez del Pozo A; Albar JP; Oñaderra M; Gavilanes JG
J Pept Res; 1998 Feb; 51(2):142-8. PubMed ID: 9580217
[TBL] [Abstract][Full Text] [Related]
24. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids.
Ladokhin AS; Selsted ME; White SH
Biophys J; 1997 Feb; 72(2 Pt 1):794-805. PubMed ID: 9017204
[TBL] [Abstract][Full Text] [Related]
25. Role of peptide structure in lipid-peptide interactions: a fluorescence study of the binding of pentagastrin-related pentapeptides to phospholipid vesicles.
Surewicz WK; Epand RM
Biochemistry; 1984 Dec; 23(25):6072-7. PubMed ID: 6525344
[TBL] [Abstract][Full Text] [Related]
26. Interaction of alpha-helical peptides with phospholipid membrane: effects of chain length and hydrophobicity of peptides.
Ohmori N; Niidome T; Hatakeyama T; Mihara H; Aoyagi H
J Pept Res; 1998 Feb; 51(2):103-9. PubMed ID: 9516044
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers.
Wyman TB; Nicol F; Zelphati O; Scaria PV; Plank C; Szoka FC
Biochemistry; 1997 Mar; 36(10):3008-17. PubMed ID: 9062132
[TBL] [Abstract][Full Text] [Related]
28. Fusogenic activity of hepadnavirus peptides corresponding to sequences downstream of the putative cleavage site.
Rodríguez-Crespo I; Núñez E; Yélamos B; Gómez-Gutiérrez J; Albar JP; Peterson DL; Gavilanes F
Virology; 1999 Aug; 261(1):133-42. PubMed ID: 10441561
[TBL] [Abstract][Full Text] [Related]
29. Interaction of staphylococcal delta-toxin and synthetic analogues with erythrocytes and phospholipid vesicles. Biological and physical properties of the amphipathic peptides.
Alouf JE; Dufourcq J; Siffert O; Thiaudiere E; Geoffroy C
Eur J Biochem; 1989 Aug; 183(2):381-90. PubMed ID: 2474443
[TBL] [Abstract][Full Text] [Related]
30. Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis.
Mishra VK; Palgunachari MN; Segrest JP; Anantharamaiah GM
J Biol Chem; 1994 Mar; 269(10):7185-91. PubMed ID: 8125930
[TBL] [Abstract][Full Text] [Related]
31. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.
Onyüksel H; Ashok B; Dagar S; Sethi V; Rubinstein I
Peptides; 2003 Feb; 24(2):281-6. PubMed ID: 12668213
[TBL] [Abstract][Full Text] [Related]
32. Relationship between antimicrobial activity and amphiphilic property of basic model peptides.
Lee S; Mihara H; Aoyagi H; Kato T; Izumiya N; Yamasaki N
Biochim Biophys Acta; 1986 Nov; 862(1):211-9. PubMed ID: 3768364
[TBL] [Abstract][Full Text] [Related]
33. Morphological behavior of acidic and neutral liposomes induced by basic amphiphilic alpha-helical peptides with systematically varied hydrophobic-hydrophilic balance.
Kitamura A; Kiyota T; Tomohiro M; Umeda A; Lee S; Inoue T; Sugihara G
Biophys J; 1999 Mar; 76(3):1457-68. PubMed ID: 10049327
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers.
Plasencia I; Rivas L; Keough KM; Marsh D; Pérez-Gil J
Biochem J; 2004 Jan; 377(Pt 1):183-93. PubMed ID: 14514353
[TBL] [Abstract][Full Text] [Related]
35. Two mode ion channels induced by interaction of acidic amphipathic alpha-helical peptides with lipid bilayers.
Lee S; Tanaka T; Anzai K; Kirino Y; Aoyagi H; Sugihara G
Biochim Biophys Acta; 1994 Apr; 1191(1):181-9. PubMed ID: 7512383
[TBL] [Abstract][Full Text] [Related]
36. Structural investigations of basic amphipathic model peptides in the presence of lipid vesicles studied by circular dichroism, fluorescence, monolayer and modeling.
Mangavel C; Maget-Dana R; Tauc P; Brochon JC; Sy D; Reynaud JA
Biochim Biophys Acta; 1998 May; 1371(2):265-83. PubMed ID: 9630666
[TBL] [Abstract][Full Text] [Related]
37. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
Zhou NE; Mant CT; Hodges RS
Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
[TBL] [Abstract][Full Text] [Related]
38. Interaction of class A amphipathic helical peptides with phospholipid unilamellar vesicles.
Gazzara JA; Phillips MC; Lund-Katz S; Palgunachari MN; Segrest JP; Anantharamaiah GM; Snow JW
J Lipid Res; 1997 Oct; 38(10):2134-46. PubMed ID: 9374135
[TBL] [Abstract][Full Text] [Related]
39. Revisiting peptide amphiphilicity for membrane pore formation.
Lorin A; Noël M; Provencher MÈ; Turcotte V; Masson C; Cardinal S; Lagüe P; Voyer N; Auger M
Biochemistry; 2011 Nov; 50(43):9409-20. PubMed ID: 21942823
[TBL] [Abstract][Full Text] [Related]
40. Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.
Machida S; Niimi S; Shi X; Ando Y; Yu Y
Biosci Biotechnol Biochem; 2000 May; 64(5):985-94. PubMed ID: 10879468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
